Unknown PHASE4 INTERVENTIONAL 2-arm NCT01889498

Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery (AZATAAR)

A Randomised Controlled Trial of the Effectiveness of Acetazolamide in Reducing Cerebrospinal Fluid Pressure for Patients Undergoing Thoracic-abdominal Aortic Repair

Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust

Conditions Thoracic Aneurysm

Interventions Acetazolamide

Updated 5 times since 2017 Last updated: Dec 30, 2014 Started: Jul 31, 2014 Primary completion: Jun 30, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01889498, this PHASE4 trial focuses on Thoracic Aneurysm and remains ongoing. Sponsored by Liverpool Heart and Chest Hospital NHS Foundation Trust, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Liverpool Heart and Chest Hospital NHS Foundation Trust

Data source: Liverpool Heart and Chest Hospital NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Liverpool, United Kingdom